Expression levels of immune checkpoint proteins such as PD-1, CTLA-4, TIM-3 and TIGIT, and checkpoint ligands including PD-L1 and galectin-9 are higher in peripheral blood or tumor tissue for CRC patients, compared with blood or colon tissue from healthy donors (160, 161). Here, HAVCR2 is linked to neoplasm.